Endocrine effects of chronic administration of psychoactive drugs to prepuberal male rats. I: delta9-tetrahydrocannabinol.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002188:Cannabis / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D013759:Dronabinol / Q000494:pharmacology*; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism; D011467:Prostate / Q000187:drug effects / Q000254:growth & development; D051381:Rats; D012701:Serotonin / Q000378:metabolism
D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D013759:Dronabinol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone; D004298:Dopamine; D009638:Norepinephrine